Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes vs. Human Liver Tissue Using Quantitative Targeted Proteomics and Cell-Surface Biotinylation.

Kumar V, Salphati L, Hop CECA, Xiao G, Lai Y, Mathias A, Chu X, Humphreys WG, Liao M, Heyward S, Unadkat JD.

Drug Metab Dispos. 2019 Jan 8. pii: dmd.118.084988. doi: 10.1124/dmd.118.084988. [Epub ahead of print]

PMID:
30622164
2.

Impact of non-cardiovascular disease burden on thirty-day hospital readmission in heart failure patients.

Kutyifa V, Rice J, Jones R, Mathias A, Yoruk A, Vermilye K, Johnson B, Strawderman R, Lowenstein C.

Cardiol J. 2018;25(6):691-700. doi: 10.5603/CJ.2018.0147.

3.

Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines.

Perriot S, Mathias A, Perriard G, Canales M, Jonkmans N, Merienne N, Meunier C, El Kassar L, Perrier AL, Laplaud DA, Schluep M, Déglon N, Du Pasquier R.

Stem Cell Reports. 2018 Nov 13;11(5):1199-1210. doi: 10.1016/j.stemcr.2018.09.015. Epub 2018 Oct 25.

4.

Nano-lipid Complex of Rutin: Development, Characterisation and In Vivo Investigation of Hepatoprotective, Antioxidant Activity and Bioavailability Study in Rats.

Ravi GS, Charyulu RN, Dubey A, Prabhu P, Hebbar S, Mathias AC.

AAPS PharmSciTech. 2018 Nov;19(8):3631-3649. doi: 10.1208/s12249-018-1195-9. Epub 2018 Oct 2.

PMID:
30280357
5.

Need for recognizing atypical manifestations of childhood sporadic acute viral hepatitis warranting differences in management.

Singh SK, Borkar V, Srivastava A, Mathias A, Yachha SK, Poddar U.

Eur J Pediatr. 2019 Jan;178(1):61-67. doi: 10.1007/s00431-018-3262-3. Epub 2018 Sep 29.

PMID:
30269249
6.

Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo.

Naz S, Sowers A, Choudhuri R, Wissler M, Gamson J, Mathias A, Cook JA, Mitchell JB.

Clin Cancer Res. 2018 Aug 15;24(16):3994-4005. doi: 10.1158/1078-0432.CCR-17-3575. Epub 2018 May 1.

PMID:
29716919
7.

Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study.

Prasad B, Bhatt DK, Johnson K, Chapa R, Chu X, Salphati L, Xiao G, Lee C, Hop CECA, Mathias A, Lai Y, Liao M, Humphreys WG, Kumer SC, Unadkat JD.

Drug Metab Dispos. 2018 Jul;46(7):943-952. doi: 10.1124/dmd.118.080523. Epub 2018 Apr 25.

PMID:
29695616
8.

The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection.

Garrison KL, German P, Mogalian E, Mathias A.

Drug Metab Dispos. 2018 Aug;46(8):1212-1225. doi: 10.1124/dmd.117.079038. Epub 2018 Apr 25. Review.

PMID:
29695614
9.

Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection.

German P, Xin Y, Chien JW, Weng W, Mackman R, Lewis SA, Meng A, Ling J, Mathias A.

J Clin Pharmacol. 2018 Apr 17. doi: 10.1002/jcph.1112. [Epub ahead of print]

PMID:
29663420
10.

Drug-Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir.

German P, Mathias A, Brainard DM, Kearney BP.

Clin Pharmacokinet. 2018 Nov;57(11):1369-1383. doi: 10.1007/s40262-018-0654-5. Review.

PMID:
29644537
11.

Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin.

Lutz JD, Kirby BJ, Wang L, Song Q, Ling J, Massetto B, Worth A, Kearney BP, Mathias A.

Clin Pharmacol Ther. 2018 Dec;104(6):1182-1190. doi: 10.1002/cpt.1073. Epub 2018 Apr 19.

12.

Cytochrome P450 3A Induction Predicts P-glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine.

Lutz JD, Kirby BJ, Wang L, Song Q, Ling J, Massetto B, Worth A, Kearney BP, Mathias A.

Clin Pharmacol Ther. 2018 Dec;104(6):1191-1198. doi: 10.1002/cpt.1072. Epub 2018 Apr 26.

13.

Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers.

Mogalian E, Stamm LM, Osinusi A, Brainard DM, Shen G, Ling KHJ, Mathias A.

Clin Infect Dis. 2018 Aug 31;67(6):934-940. doi: 10.1093/cid/ciy201.

PMID:
29522076
14.

Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.

Mogalian E, Brainard DM, Osinusi A, Moorehead L, Murray B, Ling KHJ, Perry R, Curtis C, Lawitz E, Lasseter K, Marbury T, Mathias A.

Clin Pharmacokinet. 2018 Nov;57(11):1449-1457. doi: 10.1007/s40262-018-0645-6.

PMID:
29520729
15.

Dynamical characterization of transport barriers in nontwist Hamiltonian systems.

Mugnaine M, Mathias AC, Santos MS, Batista AM, Szezech JD, Viana RL.

Phys Rev E. 2018 Jan;97(1-1):012214. doi: 10.1103/PhysRevE.97.012214.

PMID:
29448491
16.

Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus.

Babusis D, Curry MP, Kirby B, Park Y, Murakami E, Wang T, Mathias A, Afdhal N, McHutchison JG, Ray AS.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02587-17. doi: 10.1128/AAC.02587-17. Print 2018 May.

17.

Using Social Media for the Promotion of Education and Consultation in Adolescents Who Have Undergone Kidney Transplant: Protocol for a Randomized Control Trial.

Pase C, Mathias AD, Garcia CD, Garcia Rodrigues C.

JMIR Res Protoc. 2018 Jan 9;7(1):e3. doi: 10.2196/resprot.8065.

18.

Effect of matrix composition, sphere size and hormone concentration on diffusion coefficient of insulin for controlled gastrointestinal delivery for diabetes treatment.

Villaverde Cendon F, Matos Jorge RM, Weinschutz R, Mathias AL.

J Microencapsul. 2018 Jan;35(1):13-25. doi: 10.1080/02652048.2017.1409820. Epub 2017 Dec 12.

PMID:
29171778
19.

Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics.

Billington S, Ray AS, Salphati L, Xiao G, Chu X, Humphreys WG, Liao M, Lee CA, Mathias A, Hop CECA, Rowbottom C, Evers R, Lai Y, Kelly EJ, Prasad B, Unadkat JD.

Drug Metab Dispos. 2018 Feb;46(2):189-196. doi: 10.1124/dmd.117.077289. Epub 2017 Nov 14.

PMID:
29138286
20.

Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.

Mathias A, Perriot S, Canales M, Blatti C, Gaubicher C, Schluep M, Engelhardt B, Du Pasquier R.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 11;4(6):e401. doi: 10.1212/NXI.0000000000000401. eCollection 2017 Nov.

21.

Nutrient drink test: Normative values in Indian children.

Shava U, Srivastava A, Mathias A, Yachha SK, Poddar U.

Indian J Gastroenterol. 2017 Sep;36(5):405-410. doi: 10.1007/s12664-017-0794-9. Epub 2017 Oct 25.

PMID:
29071541
22.

A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy Subjects.

German P, Mathias A, Brainard DM, Song Q, Ling J, Kearney BP.

Clin Pharmacol Drug Dev. 2018 Aug;7(6):641-651. doi: 10.1002/cpdd.390. Epub 2017 Oct 23.

PMID:
29058821
23.

Performance and Health Related Characteristics of Male Athletes Using Marijuana.

Lisano JK, Smith JD, Mathias AB, Christensen M, Smoak P, Phillips KT, Quinn CJ, Stewart LK.

J Strength Cond Res. 2017 Oct 10. doi: 10.1519/JSC.0000000000002238. [Epub ahead of print]

PMID:
29023325
24.

The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.

Merienne N, Vachey G, de Longprez L, Meunier C, Zimmer V, Perriard G, Canales M, Mathias A, Herrgott L, Beltraminelli T, Maulet A, Dequesne T, Pythoud C, Rey M, Pellerin L, Brouillet E, Perrier AL, du Pasquier R, Déglon N.

Cell Rep. 2017 Sep 19;20(12):2980-2991. doi: 10.1016/j.celrep.2017.08.075.

25.

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R.

Mult Scler. 2018 Sep;24(10):1280-1287. doi: 10.1177/1352458517722646. Epub 2017 Jul 21.

26.

Hybridizing transgenic Bt cotton with non-Bt cotton counters resistance in pink bollworm.

Wan P, Xu D, Cong S, Jiang Y, Huang Y, Wang J, Wu H, Wang L, Wu K, Carrière Y, Mathias A, Li X, Tabashnik BE.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):5413-5418. doi: 10.1073/pnas.1700396114. Epub 2017 May 8.

27.

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects.

Mogalian E, German P, Kearney BP, Yang CY, Brainard D, Link J, McNally J, Han L, Ling J, Mathias A.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02084-16. doi: 10.1128/AAC.02084-16. Print 2017 May.

28.

Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.

Bacchetta F, Mathias A, Schluep M, Du Pasquier R.

Mult Scler. 2017 Feb;23(2):300-303. doi: 10.1177/1352458516670734.

PMID:
28165319
29.

EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.

Clottu AS, Mathias A, Sailer AW, Schluep M, Seebach JD, Du Pasquier R, Pot C.

Cell Rep. 2017 Jan 3;18(1):213-224. doi: 10.1016/j.celrep.2016.12.006.

30.

Long-term evaluation of fecal continence and quality of life in patients operated for anorectal malformations.

Tannuri AC, Ferreira MA, Mathias AL, Tannuri U.

Rev Assoc Med Bras (1992). 2016 Sep;62(6):544-552. doi: 10.1590/1806-9282.62.06.544.

31.

Long-term results of the Duhamel technique are superior to those of the transanal pullthrough: A study of fecal continence and quality of life.

Tannuri AC, Ferreira MA, Mathias AL, Tannuri U.

J Pediatr Surg. 2017 Mar;52(3):449-453. doi: 10.1016/j.jpedsurg.2016.10.007. Epub 2016 Oct 19.

PMID:
27836370
32.

Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.

Srivastava A, Chaturvedi S, Gupta RK, Malik R, Mathias A, Jagannathan NR, Jain S, Pandey CM, Yachha SK, Rathore RKS.

J Hepatol. 2017 Mar;66(3):528-536. doi: 10.1016/j.jhep.2016.10.026. Epub 2016 Nov 1.

PMID:
27815224
33.

Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C.

German P, Mathias A, Brainard D, Kearney BP.

Clin Pharmacokinet. 2016 Nov;55(11):1337-1351. Review.

PMID:
27193156
34.

Prevalence of celiac disease in Indian children with type 1 diabetes.

Srivastava A, Chaturvedi S, Dabadghao P, Mathias A, Shukla U, Singh U, Yachha SK.

Indian J Gastroenterol. 2016 Sep;35(5):372-378. Epub 2016 Sep 24.

PMID:
27663711
35.

Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.

Mathias A, Moss AJ, McNitt S, Zareba W, Goldenberg I, Solomon SD, Kutyifa V.

J Am Coll Cardiol. 2016 Sep 20;68(12):1268-76. doi: 10.1016/j.jacc.2016.06.051.

36.

Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics.

Wang L, Collins C, Kelly EJ, Chu X, Ray AS, Salphati L, Xiao G, Lee C, Lai Y, Liao M, Mathias A, Evers R, Humphreys W, Hop CE, Kumer SC, Unadkat JD.

Drug Metab Dispos. 2016 Nov;44(11):1752-1758. Epub 2016 Aug 19.

37.

Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.

Mathias A, Perriard G, Canales M, Soneson C, Delorenzi M, Schluep M, Du Pasquier RA.

Mult Scler. 2017 May;23(6):802-809. doi: 10.1177/1352458516664210. Epub 2016 Aug 8.

PMID:
27503907
38.

Effect of oral administration of Tribulus terrestris extract on semen quality and body fat index of infertile men.

Salgado RM, Marques-Silva MH, Gonçalves E, Mathias AC, Aguiar JG, Wolff P.

Andrologia. 2017 Jun;49(5). doi: 10.1111/and.12655. Epub 2016 Jul 12.

PMID:
27401787
39.

Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).

Ziemssen T, Phillips G, Shah R, Mathias A, Foley C, Coon C, Sen R, Lee A, Agarwal S.

J Neurol. 2016 Oct;263(10):1969-83. doi: 10.1007/s00415-016-8210-4. Epub 2016 Jul 8.

PMID:
27393117
40.

Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.

Hall JC, Marlow LA, Mathias AC, Dawson LK, Durham WF, Meshaw KA, Mullin RJ, Synnott AJ, Small DL, Krishna M, von Hoff D, Schüler J, Hart SN, Couch FJ, Colon-Otero G, Copland JA.

J Transl Med. 2016 May 10;14(1):129. doi: 10.1186/s12967-016-0875-z.

41.

The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.

Mathias A, Perriard G, Canales M, Vuilleumier F, Perrotta G, Schluep M, Du Pasquier R.

Neurol Neuroimmunol Neuroinflamm. 2016 Feb 10;3(2):e209. doi: 10.1212/NXI.0000000000000209. eCollection 2016 Apr.

42.

A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus.

Ahn SH, Lim YS, Lee KS, Paik SW, Lee YJ, Jeong SH, Kim JH, Yoon SK, Yim HJ, Tak WY, Han SY, Yang JC, Mo H, Mathias A, Han L, Knox SJ, Brainard DM, Kim YJ, Byun KS, Kim YS, Heo J, Han KH.

J Viral Hepat. 2016 May;23(5):358-65. doi: 10.1111/jvh.12499. Epub 2016 Feb 10.

PMID:
26864153
43.

Classical Galactosemia Among Indian Children: Presentation and Outcome from a Pediatric Gastroenterology Center.

Sarma MS, Srivastava A, Yachha SK, Poddar U, Mathias A.

Indian Pediatr. 2016 Jan;53(1):27-31.

44.

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

Kao JH, Chien RN, Chang TT, Peng CY, Hu TH, Lo GH, Wang HY, Chen JJ, Yang JC, Knox SJ, Han L, Mo H, Mathias A, Brainard DM, Sheen IS, Hsu YC, Chu CJ, Chuang WL.

Liver Int. 2016 Aug;36(8):1101-7. doi: 10.1111/liv.13082. Epub 2016 Mar 23.

45.

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.

Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, Yaldizli Ö, Regeniter A, Derfuss T, Canales M, Schluep M, Du Pasquier R, Krueger G, Granziera C.

Mult Scler. 2016 Oct;22(12):1550-1559. Epub 2016 Jan 11.

PMID:
26754800
46.

[Validation of questionnaires to assess quality of life related to fecal incontinence in children with anorectal malformations and Hirschsprung's disease].

Mathias AL, Tannuri AC, Ferreira MA, Santos MM, Tannuri U.

Rev Paul Pediatr. 2016 Jan-Mar;34(1):99-105. doi: 10.1016/j.rpped.2015.06.006. Epub 2015 Oct 9. Portuguese.

47.

Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.

Mogalian E, German P, Kearney BP, Yang CY, Brainard D, McNally J, Moorehead L, Mathias A.

Clin Pharmacokinet. 2016 May;55(5):605-13. doi: 10.1007/s40262-015-0334-7.

PMID:
26519191
48.

CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients.

Avelino-Silva VI, Miyaji KT, Mathias A, Costa DA, de Carvalho Dias JZ, Lima SB, Simoes M, Freire MS, Caiaffa-Filho HH, Hong MA, Lopes MH, Sartori AM, Kallas EG.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):189-95. doi: 10.1097/QAI.0000000000000845.

PMID:
26361176
49.

Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.

Biton Y, Moss AJ, Kutyifa V, Mathias A, Sherazi S, Zareba W, McNitt S, Polonsky B, Barsheshet A, Brown MW, Goldenberg I.

Circ Heart Fail. 2015 Sep;8(5):921-6. doi: 10.1161/CIRCHEARTFAILURE.115.002208. Epub 2015 Jul 15.

PMID:
26179186
50.

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, Schaeren-Wiemers N, Du Pasquier RA.

J Neuroinflammation. 2015 Jun 16;12:119. doi: 10.1186/s12974-015-0335-3.

Supplemental Content

Loading ...
Support Center